From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection

Sexually Transmitted Infections

Volumn 75, Issue 1, 1999, Pages 3-17

  Fleming, Douglas T ^a,b   Wasserheit, Judith N ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Epidemiology; HIV; Public health policy; Sexual transmission; Sexually transmitted diseases

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; CD4 ANTIGEN; CIPROFLOXACIN; IRON; MEBENDAZOLE; METRONIDAZOLE; MULTIVITAMIN; RECEPTOR; VIRUS ANTIBODY;

BACTERIUM CULTURE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; ENZYME IMMUNOASSAY; GENITAL HERPES; GENITAL ULCER; GONORRHEA; GRAM STAINING; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH SERVICE; HEMAGGLUTINATION TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAMUSCULAR DRUG ADMINISTRATION; LIGASE CHAIN REACTION; MATHEMATICAL MODEL; ORAL DRUG ADMINISTRATION; PHYSICAL EXAMINATION; POLICY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REAGIN TEST; REVIEW; SEROCONVERSION; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SYPHILIS;

EID: 0033017798     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.75.1.3     Document Type: Review

References (82)

1. Centers for Disease Control and Prevention. Gonorrhea among men who have sex with men - selected sexually transmitted diseases clinics, 1993-1996. MMWR 1997;46:889-9.
2. Institute of Medicine. The hidden epidemic: confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1997.
3. Panel on Reproductive Health, et al. In: Tsui AO, Wasserheit JN, Haaga JG, eds. Reproductive health in developing countries: expanding dimensions, building solutions. Washington, DC: National Academy Press, 1997.
4. Landry DJ, Forrest JD. Public health departments providing sexually transmitted disease services. Fam Plan Perspect 1996;28:261-6.
5. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. [Review] Sex Transm Dis 1992;19:61-77.
6. Clottey C, Dallabetta G. Sexually transmitted diseases and human immunodeficiency virus. Epidemiologic synergy? [Review] Infect Dis Clin N Am 1993;7:753-70.
7. Mastro TD, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS 1996;10 Suppl A:S75-82.
8. Kreiss JK, Coombs R, Plummer F, et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989;160:380-4.
9. Plummer FA, Wainberg MA, Plourde P, et al. Detection of human immunodeficiency virus type 1 (HIV-1) in genital ulcer exudate of HIV-1-infected men by culture and gene amplification [letter]. J Infect Dis 1990;161:810-11.
10. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997;11:F85-93.
11. Dyer JR, Eton JJ, Hoffman IF, et al. Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J Infect Dis 1998;177:224-7.
12. Schacker T, Ryncarz A, Goddard J, et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998;280:61-6.
13. Mole L, Ripich S, Margolis D, et al. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997;176:766-70.
14. Spinola SM, Orazi A, Arno JN, et al. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis 1996;173:394-402.
15. Stamm WE, Handsfield HH, Rompalo AM, et al. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988;260:1429-33.
16. Magro, CM, Crowson AN, Alfa M, et al. A morphological study of penile chancroid lesions in human immunodeficiency virus (HIV)-positive and -negative African men with a hypothesis concerning the role of chancroid in HIV transmission. Human Pathol 1996;27:1066-70.
17. Van Laer L, Vingerhoets J, Vanham G, et al. In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV- and HIV+ chancroid patients by Haemophilus ducreyi antigens. Clin Exp Immunol 1995;102:243-50.
18. Heng MC, Heng SY, Allen SG. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 1994;343:255-8.
19. Pleskoff O, Treboute C, Brelot, A, et al. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 1997;276:1874-8.
20. Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. J Infect Dis 1995;172:1469-74.
21. Anderson DJ, O'Brien TR, Politch JA, et al. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type I in semen [see comments]. JAMA 1992;267:2769-74.
22. Atkins MC, Carlin EM, Emery VC, et al. Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ 1996;313: 341-2.
23. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997;349:1868-73.
24. Eron JJ, Jr, Gilliam B, Fiscus S, et al. HIV-1 shedding and chlamydial urethritis [letter; comment]. JAMA 1996;275: 36.
25. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 from the cervix and vagina. Lancet 1907;350:922-7.
26. Clemetson DB, Moss GB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA 1993;269:2860-4.
27. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994; 170:1597-601.
28. John G, Nduati R, Mbori-Ngach D, et al. Genital shedding of human immunodeficiency virus type I DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997;175:57-62.
29. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with non-ulcerative sexually transmitted diseases. J Infect Dis 1998;177:167-74.
30. Ho JL, He S, Hu A, et al. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. Exp Med 1995;181: 1493-505.
31. Dallabetta GA, Miotti PG, Chiphangwi JD, et al. Traditional vaginal agents: use and association with HIV infection in Malawian women. AIDS 1995;9:293-7.
32. Dickerson MC, Johston JJ, Delea TE, et al. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis 1996;23:429-40.
33. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men [see comments]. Lancet 1989;2:403-7.
34. Mbizvo MT, Machekano R, McFarland W, et al. HIV seroincidence and correlates of seroconversion in a cohort of male factory workers in Harare, Zimbabwe. AIDS 1996; 10:895-901.
35. Nopkesorn T, Mock PA, Mastro TD et al. HIV-1 subtype E incidence and sexually transmitted diseases in a cohort of military conscripts in northern Thailand. J Acq Immun Def Synd Human Retrovirol 1998;18:372-9.
36. Nelson KE, Eiumtrakul S, Celentano D, et al. The association of herpes simplex virus type 2 (HSV-2), haemophilus ducreyi, and syphilis with HIV infection in young men in northern Thailand. J Acq Immun Def Synd Human Retrovirol 1997;16:293-300.
37. Telzak EE, Chiasson MA, Bevier PJ, et al. HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med 1993;119: 1181-6.
38. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission ofhuman immunodeficiency virus type 1. J Infect Dis 1991;163:233-9.
39. De Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994;331:341-6.
40. Kassler VU, Zenilman JM, Erickson B, et al. Seroconversion in patients attending sexually transmitted disease clinics. AIDS 1994;8:351-5.
41. Mehendale SM, Rodrigues JJ, Brookmeyer RS, et al. Incidence and predictors of human immunodeficiency virus type I seroconversion in patients attending sexually transmitted disease clinics in India. J Infect Dis 1995;172: 1486-91.
42. Holmberg SD, Stewart JA, Gerber AR. Prior herpes simplex virus type 2 infections as a risk factor for HIV infection. JAMA 1988;259:1048-50.
43. Keet IPM, Lee FK, van Griensven GJP, et al. Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition. Genitourin Med 1990; 66:330-3.
44. Kingsley LA, Armstrong J, Rahman A, et al. No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acqu Immun Def Syn 1990;3:773-9.
45. Kuiken CL, van Griensven GJ, de Vroome EM, et al. Risk factors and changes in sexual behavior in male homosexuals who seroconverted for human immunodeficiency virus antibodies. Am J Epiderm 1990;132:523-30.
46. Craib KJ, Meddings DR, Strathdee SA, et al. Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men. Genitourin Med 1995;71:150-4.
47. Dominguez KL, Ellerbrock TV, Harrington PE, et al. Risk factors for HIV seroconversion among young women in a rural community in the southeastern United States. XI International Conference on AIDS, Vancouver, July 7-12, 1996; abstract No C 222.
48. Darrow WW, Echenberg DF, Jaffe HW, et al. Risk factors for human immunodeficiency virus (HIV) infections in homosexual men. Am J Public Health 1987;77:479-83.
49. Otten MW Jr, Zaidi AA, Peterman TA, et al. High rate of HIV seroconversion among patients attending urban sexually transmitted disease clinics. AIDS 1994;8:549-53.
50. Kilmarx PH, Limpakarnjanarat K, Saisorn S, et al. Incident HIV-1 infection and sexually transmitted diseases among female sex workers in Upper Northern Thailand (abstract). In: Fourth International Congress on AIDS in Asia and the Pacific. Manila, Philippines, 1997: C(P)065.
51. Plourde PJ, Pepin J, Agoki E, et al. Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. J Infect Dis 1994;170:313-17.
52. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study [see comments]. AIDS 1993;7:95-102.
53. Kapiga S, Lyamuya EF, Lwihula GK, et al. The incidence of HIV infection among women using family planning methods in Dar-es-Salaam, Tanzania. AIDS 1998;12:75-84.
54. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998;12:1699-706.
55. Weir SS, Feldblum, PJ, Roddy RE, et al. Gonorrhea as a risk factor for HIV acquisition. AIDS 1994;8:1605-8.
56. Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997;350:546-50.
57. Miettenen OS. Proportion of disease caused or prevented by a given exposure, trait, or intervention. Am J Epidemiol 1974;99:325-32.
58. Vittinghoff E, Padian NS. Attributable risk of exposures associated with sexually transmitted disease. J Infect Dis 1996;174 (Suppl 2):S182-7.
59. Hayes RJ, Schulz KF, Plummer FA. The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. [Review] J Twp Med Hyg 1995;98:1-8.
60. Boily MC, Anderson RM. Human immunodeficiency virus transmission and the role of other sexually transmitted diseases. Measures of association and study design. Sex Transm Dis 1996;23:312-32.
61. Boily MC. Transmission dynamics of co-existing chlamydial and HIV infections in the United States. In: The hidden epidemic: confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1996:C1-13.
62. May R, Anderson R. Transmission dynamics of HIV infection. Nature 1987;326:137-42.
63. Boily MC, Brunham RC. The impact of HIV and other STDs on human populations. Are predictions possible? Infect Dis Clin N Am 1993;7:771-92.
64. Robinson NJ, Mulder DW, Auvert B, et al. Proportion of HIV infections attributable to other sexually transmitted diseases in a rural Ugandan population: simulation model estimates. Int J Epidemiol 1997;26:180-9.
65. Garnett GP, Anderson RM. Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus. J Acquir Immun Defic Syndr Hum Retrovirol 1995;9:500-13.
66. Over M, Plot P. Human immunodeficiency virus infection and other sexually transmitted diseases in developing countries: public health importance and priorities for resource allocation. J Infect Dis 1996;174 (suppl 2):162-75.
67. World Bank. Confronting AIDS: public priorities in a global epidemic. Washington, DC: International Bank for Reconstruction and Development/World Bank 1997:1-14.
68. Mertens TE, Hayes RJ, Smith PG. Epidemiological methods to study the interaction between HIV infection and other sexually transmitted diseases. [Review] AIDS 1990;4:57-65.
69. Laga M, Diallo, MO, Buve A. Interrelationship of sexually transmitted diseases and HIV: where are we now? AIDS 1994;8 (Suppl 1):S119-24.
70. Hayes RJ, Wawer M, Gray R, et al. Randomised trials of STD treatment for HIV prevention: report of an international workship. Genitourin Med 1997;73:432-43.
71. Nkowane BM, Lwanga SK. HIV and design of intervention studies for control of sexually transmitted diseases. AIDS 1990;4 (Suppl 1):S123-6.
72. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994;344:246-8.
73. Plummer F. HIV and STD incidence in a sex worker cohort: 1985-1997. Presentation at the UNAIDS-WHO Consultation on STD Interventions for Preventing HIV: what is the Evidence? Geneva: WHO, 14-16 October 1998.
74. Levine WC, Revollo R, Kaune V, et al. Decline in sexually transmitted disease prevalence in female Bolivian sex workers: impact of an HIV prevention project. AIDS 1998; 12: 1899-906.
75. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial [see commentsl. Lancet 1995;346:530-6.
76. Mayaud P, Mosha F, Todd J, et al. Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomized controlled trial. AIDS 1997;11:1873-80.
77. Gilson I, Mkanje R, Grosskurth H, et al. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet 1997;350:1805-9.
78. Wawer MJ, Gray RH, Sewankambo NK, et al. Results of a randomized, community trial of STD control for AIDS prevention, Rakai District, Uganda: reductions in STDs are not associated with reduced HIV incidence. Lancet, in press.
79. Laga M, Dallabetta G. Treating the whole syndrome. Lancet 1997;350 (suppl III):25.
80. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 1998;351 (suppl III):5-7.
81. Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases - United States. MMWR 1998;47(No RR-12):1-24.
82. Dallabetta GA, Gerbase AC, Holmes KK. Problems, solutions, and challenges in syndromic management of sexually transmitted diseases. Sex Transm Infect 1998;74 (Suppl 1):S1-11.